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Abstract: Erythromelalgia is a rare clinical syndrome characterized by heat, redness and intermittent pain
in the extremities, being most frequent the bilateral development in the lower extremities. Local cooling
brings relief to symptoms, while heating, physical exercises and use of stockings/socks intensify the discomfort. This condition can be primary or idiopathic or secondary to haematological disorders and vascular inflammatory and degenerative diseases. It is reported the case of an eighteen-year-old male who
presented, at the early age of two, development of the symptoms of erythema ,heat and pain followed by
desquamation of hands and feet, in outbreaks, with intervals 4 to 5 years long between the crises.
Keywords: Erythema; Erythromelalgia; Hot temperature; Pain
Resumo: Eritromelalgia é uma síndrome clínica rara, caracterizada por calor, rubor e dor intermitente
nas extremidades, sendo frequente o acometimento bilateral das extremidades inferiores. O resfriamento local provoca alívio dos sintomas, enquanto aquecimento, exercícios físicos e uso de luvas e meias
intensificam o desconforto. A desordem pode ser primária ou idiopática, ou secundária a distúrbios
hematológicos e doenças vasculares inflamatórias e degenerativas. Relata-se o caso de um jovem de
dezoito anos, com início precoce aos dois anos de idade dos sintomas de eritema, calor e dor, seguidos
de descamação nas mãos e pés, em surtos, com intervalos longos de 4 a 5 anos entre as crises.
Palavras-chave: Dor; Eritema; Eritromelalgia; Temperatura alta

INTRODUCTION
Erythromelalgia, a rare condition described initially by Mitchell in 1878,1 is characterized by the triad
of paroxysmal hyperthermia of the extremities with
erythema, pain and intense burning and increase in
skin temperature.2 The disease manifests itself primarily in the feet and the hands but it can also affect the
ears although less frequently.1 Heat exposure, physical exercises, gravity and the use of stockings/socks
and gloves can act as triggers of the symptoms or
intensify the discomfort while cold causes discomfort

relief.3-5 The disease takes typically a chronic course
and it is associated with a decrease in the quality of life
and considerable morbidity. It differs from Lane’s palmoplantar erythema or red palms syndrome – a congenital, familial and hereditary dysplasia characterized
by persistent and symmetric redness, without subjective manifestations - due to the intermittent nature of
the symptoms.6 Erythromelalgia can be classified as
primary or secondary, depending that if the absence
or presence respectively of associated diseases that
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may precede it, coincides with the beginning of the
disease or occurs during its evolution.1 The primary
form can be classified in familiar (autosomal dominant) or sporadic, and in juvenile onset (before 20
years of age, frequently before 10 years) or adult
onset. Familiar erythromelalgia of juvenile onset is
associated with mutations in the gene SCN9A that codifies a voltage-dependent sodium channel and it is
more frequent in male.1,5 Secondary erythromelalgia
can be associated with various disorders like thrombocytopenia, polycythemia, myeloproliferative disorders, hypertension, vasculitis, systemic lupus erythematous, scleroderma, rheumatoid arthritis, Raynaud’s
disease, HIV and gout.1,2,4-5,7-8 It has a late beginning,
from the third decade onwards, without preference of
sex. The incidence of erythromelalgia estimated in the
Norwegian population was from 0,25 to 0,33 per
100.000 inhabitants per year.5 As in Olmsted,
Minnesota, such incidence was greater, of 1,3 per
100.000 inhabitants per year, being 1,1 and 0,2 per
100.000 inhabitants per year the incidence of the primary and secondary forms respectively.7
Etiopathogenesis of erythromelalgia is not
known yet but it is admitted the existence of primary
or secondary vascular abnormalities that result in
endothelial edema, with increase in temperature and
blood flow, hypoxia, platelet aggregation and activation, with release of prostaglandins which produces
erythema and pain.3-5 It was also observed the presence of small-fiber neuropathy.9 Its treatment includes
drugs that act in the neuropathy such as gabapentin,
tricyclic antidepressants and selective inhibitors of
serotonin reuptake, and, in vasculopathy, drugs like
acetylsalicylic acid, ‚-blockers and calcium channel
antagonists.5 However, the responses vary a lot and
remission of symptoms is rarely observed.1

DISCUSSION
Diagnosis of erythromelalgia is essentially clinical. The disease is characterized by the triad of paroxysmal hyperthermia of the extremities with erythema,
pain and intense burning and increase in skin 2 As for
the case presented here, it was reported improvement
of the symptoms with local cooling and worsening
with heat exposure, facts that corroborated the diagnosis of the disease.
Due to the absence of comorbidities our patient
was classified as carrier of the primary form of the disease which is characterized by early onset of symptoms which was, in this case, at the age of two, and
greater prevalence in male.
In erythromelalgia, the palmoplantar onset is
the most common.5 In a retrospective study Davis et
al. described the location of erythromelalgia in 168
patients, and in 148 patients the feet were affected
(88,1%). In 42 patients (25,6%), hands were affected
while just one patient had the ears affected.10
In some patients erythromelalgia is reversible
and remissions might last months or years or can even
be a complete cure. This confirms the observations of
Kalgaard et al. that suggest that erythromelalgia is not
an isolated disease but that it is a pattern of response
of cutaneous microvasculature 8 In a prospective study

CASE REPORT
Eighteen-year-old male adolescent, Caucasian,
single, student, born and coming from Recife-PE
sought the dermatology clinic with complaints of
episodes of redness, heat and pain in hands and feet,
followed by desquamation, with duration of 15 days.
The symptoms had started when he was 2 years old ,
with intervals between the crises varying from 4 to 5
years, when the patient remained asymptomatic. The
symptoms worsened with exposition to heat and
relieved with local cooling. In two occasions he
reported the onset of crises after staying too long in a
queue, and also after a football match. He denied systemic symptoms and he did not present any other
comorbidities or family history.
Physical examination proved that the patient
was in good health only with erythema and heat in
palms and soles (Pictures 1, 2 and 3), being requested

FIGURE 1: Difuse erythema on soles
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laboratory exams and behavioral methods were taught
to him. .After eight days he returned with strong
desquamation in plantar and palmar surfaces, with
erythema in the subjacent skin (Pictures 4 and 5), this
receded after seven days. Blood count and uric acid
were normal. Serology for HIV, ANA and RF was not
reactive. The patient had another crisis after 15 days,
this time with a less pronounced erythema and resolution of the symptoms in a week.

Primary erythromelalgia - Case report

FIGURE 2: Difuse erythema on plant and dorse of feet

FIGURE 3: Erythema on palms of the hands

Davis et al. observed that erythromelalgia is associated with a neuropathy of small fibers and primary vasculopathies, characterized by an intermittent increase
of blood flow, hypoxia, and possibly shunts, with
increase in local cellular metabolism.9,11 Due to the
hypothesis of shunts, substances that alter the distribution of skin blood flow can improve the cutaneous
oxygenation and induce symptoms relief. Aspirin,
which inhibits platelet aggregation can quickly relief
the secondary symptoms of coagulopathy. Mork et al.,
in a double-blind controlled placebo prospective
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FIGURE 4: Desquamation on palms after eight days from the
beginning of the crisis

FIGURE 5:
Pronounced desquamation on soles after
eight days of the crisis

study in 21 patients observed that the analogue of oral
PGE1, misoprostol, given on a 0,4 a 0,8 mg/day for 6
weeks , determined a significant reduction of the pain
symptoms and local erythema but this decrease did
not persist and after three months of treatment no further continuation was required.3
As the responses for the current available treatments varies a lot, it was chosen as a more conservative treatment for our patient who had been presenting long periods between the crises (5 years) and limited duration (two weeks) of the symptoms.
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